Dr Reddy?

Dr Reddy?

WebDr. Reddy’s Q3 & 9M FY23 Financial Results . Hyderabad, India, January 25, 2024: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 NSE: DRREDDY NYSE: RDY NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and the nine months ended December 31, 2024.The information mentioned in this release is on the … WebJan 31, 2024 · Published. Jan 31, 2024 1:10PM EST. Dr. Reddy's Laboratories Limited RDY reported third-quarter fiscal 2024 earnings of 57 cents per American Depositary Share compared with 41 cents (excluding ... andre the giant hand with beer can WebJan 27, 2024 · Dr Reddy's Lab Q3 PAT soars 76% to Rs 1,247 cr Subros consolidated net profit rises 247.76% in the June 2024 quarter ... Free cash-flow stood at Rs 1,980 crore and net cash surplus for the company is at Rs 3,400 crore as on 31 December 2024. Commenting on the results, co-chairman & MD, G V Prasad said, "Our strong financial … WebMar 24, 2024 · Dr. Reddy's Laboratories Ltd. ADR analyst estimates, including RDY earnings per share estimates and analyst recommendations. ... Q4 2024 Q1 2024 Q2 2024 Q3 2024; Estimate: 0.51 0.51 0.56 0.68 ... bacq forme WebDr. Reddys Laboratories Limited January 25, 2024 Page 2 of 16 Moderator: Ladies and gentlemen, good day, and welcome to Dr. Reddy's Laboratories Limited Q3 FY '23 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. WebKey ratios of the Dr Reddys Laboratories Ltd post its Q3 2024-2024 results. Earning Per Share (EPS) 219.52. Return on Equity (ROE) 9.19. Dividend Per Share (DPS) 30. ... Dr Reddy's Laboratories Ltd was founded in 1984 and is based in Hyderabad, India. ... Dr Reddys Laboratories Ltd Listing date: 11 Mar, 1994 Dr Reddys Laboratories Ltd ... andre the giant harley race WebJan 25, 2024 · Hyderabad: Dr. Reddy’s Laboratories Ltd. (BSE: 500124 NSE: DRREDDY NYSE: RDY NSEIFSC: DRREDDY) today announced its consolidated financial results for the quarter and the nine months ended December 31, 2024. The information mentioned in this release is on the basis of consolidated financial statements under International …

Post Opinion